Congenital Abnormalities: Clinical Trials

112 trials for Congenital Abnormalities, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

112 unknown. 112 Phase 2, 21 Phase 1, 21 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 2112Unknown 112
Phase 121Unknown 21
Phase 321Unknown 21

Follow Congenital Abnormalities: new trials by email Literature Review of Congenital Abnormalities trials Research Report on Congenital Abnormalities

Trials (filtered) newest first · largest first

All 112 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Vosoritide for Short Stature in Turner Syndrome
Vosoritide - Turner Syndrome, Short Stature
Phase 2UnknownRoopa Kanakatti Shankar, MBBS, MS202024-04-122024-06-24
CVL237 Tablets for APDS/PASLI
CVL237 tablets, CVL237 placebo tablets - PI3K and P110delta Hyperactivation Syndrome
Phase 2 / Phase 3UnknownConvalife (Shanghai) Co., Ltd.352024-03-302024-03-05
Preventive Effect of Perinatal Oral Probiotic Supplementation (POPS) on Neonatal Jaundice
Vivomixx®, Placebo - Neonatal Jaundice, Microtia
Phase 2UnknownChinese University of Hong Kong942024-03-232024-05-20
Assessment of Therapeutic Effect of Rectal Vs. Intravenous Paracetamol in The Treatment of Patent Ductus Arteriosus (PDA) in Neonates
Paracetamol - Patent Ductus Arteriosus
Phase 1 / Phase 2UnknownSoha mahmoud Hussien mahdy1002024-03-012024-02-13
Tirzepatide Monotherapy in Patients With Wolfram Syndrome Type 1
Tirzepatide - Wolfram Syndrome
Phase 2UnknownOspedale San Raffaele102024-01-012024-02-22
Comparision Between Paracetamol and Ibuprofen in Closure of Patent Ductus Arteriosus
Paracetamol, Ibuprofen - Patent Ductus Arteriosus
Phase 2UnknownAssiut University562023-12-012023-12-01
Treat Autosomal Dominant Polycystic Kidney Disease With Oral Ketone Ester?
Ketone ester - ADPKD
Phase 2UnknownUniversitair Ziekenhuis Brussel202023-11-012023-10-25
Part II: Granulocyte-Colony Stimulating Factor Adjunct Therapy for Biliary Atresia
Filgrastim - Biliary Atresia
Phase 2UnknownHolterman, Ai-Xuan, M.D.4002023-09-012023-09-08
Hereditary Sensory Neuropathy Serine Trial
L-serine, Placebo - Hereditary Sensory Neuropathy Type I
Phase 2UnknownUniversity College, London502023-08-212023-11-02
Evaluation of Antimicrobial Photodynamic Therapy and Minimal Intervention Associated With Deproteinization in Permanent Teeth With Molar Incisor Hypomineralization
Antimicrobial PDT and Papacarie Deproteinization, Conventional caries treatment, Antimicrobial PDT and 5% NaOCl Deproteinization - Hypomineralization Molar Incisor
Phase 1 / Phase 2UnknownUniversity of Nove de Julho692023-08-202023-11-28
Pazopanib for the Treatment of Epistaxis in Hereditary Hemorrhagic Telangiectasia
Pazopanib - Hereditary Hemorrhagic Telangiectasia, Epistaxis
Phase 1 / Phase 2UnknownCure HHT302023-07-012022-09-08
Study to Evaluate Safety and Efficacy of ALLO-ASC-SHEET in Subjects With Dystrophic Epidermolysis Bullosa
ALLO-ASC-SHEET, Vehicle Control - Dystrophic Epidermolysis Bullosa
Phase 2UnknownAnterogen Co., Ltd.62023-05-012024-04-22
68Ga-NY104 PET/CT in Von Hippel-Lindau Disease
68Ga-NY104 PET/CT Contrast-enhanced MRI of the brain and contrast-enhanced CT of abdomen and pelvis) 68Ga-NODAGA-LM3 PET/CT (exploratory) - Von Hippel-Lindau Disease
Phase 2UnknownPeking Union Medical College Hospital192023-05-012023-05-11
Study of PTW-002 in Patients With Dominant or Recessive Dystrophic Epidermolysis Bullosa Due to Mutation(s) in Exon 73 of the COL7A1 Gene
PTW-002 10 mg/g gel, Placebo - Dystrophic Epidermolysis Bullosa
Phase 1 / Phase 2UnknownPhoenicis Therapeutics82023-04-302023-03-31
Research of SORD-CMT Natural History and Epalrestat Treatment
Epalrestat - Charcot-Marie-Tooth Disease (CMT)
Phase 2UnknownThe Third Xiangya Hospital of Central South University302023-04-012023-04-18
A Multi-Center Study on the Use of Rho-Kinase Inhibitor to Reduce or Prevent PVR in RRD Eyes at High Risk for PVR
Netarsudil 0.02% Ophthalmic Solution [RHOPRESSA], Glycerin 0.2%/Hypromellose 0.2%/Peg 1%/Soln,Oph,Ud - Rhegmatogenous Retinal Detachment, Proliferative Vitreoretinopathy
Phase 2 / Phase 3UnknownWills Eye802023-02-062024-07-30
" Evaluation of Safety and Efficacy of Empagliflozin and Sacubitril/Valsartan for CHF With Reduced Ejection Fraction in ACHD "
Sacubitril 49 MG / Valsartan 51 MG [Entresto] BID, Empagliflozin 10 MG OD - Congenital Heart Disease, Heart Failure
Phase 2 / Phase 3UnknownInstituto Nacional de Cardiologia Ignacio Chavez1602023-02-062022-11-02
BR790 in Combination With Anlotinib in Adult Subjects With Advanced Non-Small Cell Lung Cancer
BR790+anlotinib - Non-Small Cell Lung Cancer
Phase 1 / Phase 2UnknownShanghai Gopherwood Biotech Co., Ltd.902023-02-012023-02-10
Efficacy of Bumetanide to Improve Cognitive Functions in Down Syndrome
Bumetanide, Placebo - Down Syndrome
Phase 2UnknownStefano Vicari642023-01-112024-06-20
Pharmacological Treatment on the Recovery of Neurosensory Disturbance After Bilateral Sagittal Split Osteotomy
Orthognathic Surgery, Melatonin 10 MG Oral Tablet, Hydroxycobalamin - Retrognathism, Prognathism
Phase 2 / Phase 3UnknownUniversitat Internacional de Catalunya2202022-09-302022-09-13

Showing 20 of 112. Sign in to see all of them.

Narrower conditions

Heart Defects, Congenital (12)  ·  Ductus Arteriosus, Patent (8)  ·  Leukemia (6)  ·  Leukemia, Myeloid, Acute (6)  ·  Epidermolysis Bullosa Dystrophica (5)  ·  Hereditary Sensory and Autonomic Neuropathies (4)  ·  Tuberous Sclerosis (4)  ·  Burkitt Lymphoma (3)  ·  Epidermolysis Bullosa Simplex (3)  ·  Foramen Ovale, Patent (3)  ·  Heart Failure (3)  ·  Hernias, Diaphragmatic, Congenital (3)  ·  Hodgkin Disease (3)  ·  Leukemia, Erythroblastic, Acute (3)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (112)  ·  Cardiovascular Diseases (47)  ·  Genetic Diseases, Inborn (46)  ·  Cardiovascular Abnormalities (40)  ·  Heart Diseases (34)  ·  Pathological Conditions, Signs and Symptoms (31)  ·  Nervous System Diseases (29)  ·  Heart Defects, Congenital (22)  ·  Abnormalities, Multiple (17)  ·  Neoplasms (16)  ·  Skin and Connective Tissue Diseases (16)  ·  Female Urogenital Diseases (15)  ·  Female Urogenital Diseases and Pregnancy Complications (15)  ·  Male Urogenital Diseases (15)

Interventions

Acetaminophen (5)  ·  Dexmedetomidine (3)  ·  Ibuprofen (3)  ·  Antilymphocyte Serum (2)  ·  Cyclosporine (2)  ·  Cytarabine (2)  ·  Everolimus (2)  ·  Gentamicins (2)  ·  Losartan (2)  ·  Melatonin (2)  ·  Metformin (2)  ·  Mycophenolic Acid (2)  ·  Propranolol (2)  ·  Saline Solution (2)  ·  Sirolimus (2)

Sponsors

Shaare Zedek Medical Center (4)  ·  Massachusetts General Hospital (3)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (2)  ·  Assiut University (2)  ·  Cardiff University (2)  ·  Clinuvel Europe Limited (2)  ·  Ethicare GmbH (2)  ·  European Organisation for Research and Treatment of Cancer - EORTC (2)  ·  Herbert Irving Comprehensive Cancer Center (2)  ·  NMT Medical (2)  ·  Peking Union Medical College Hospital (2)  ·  Radboud University Medical Center (2)  ·  Seoul National University Hospital (2)  ·  Tel-Aviv Sourasky Medical Center (2)  ·  University of Nove de Julho (2)

Countries

United States (23)  ·  China (12)  ·  Netherlands (12)  ·  United Kingdom (10)  ·  Italy (7)  ·  Israel (6)  ·  Belgium (5)  ·  France (5)  ·  Brazil (4)  ·  Egypt (4)  ·  Canada (3)  ·  Germany (3)  ·  Mexico (3)  ·  Spain (3)  ·  Austria (2)

Top investigators

Cathy Hammerman, MD (4)  ·  Christoph Male, Prof,MD,PhD (2)  ·  David G. Savage, MD (2)  ·  Ida Jovanovic, Prof,MD,PhD (2)  ·  Mark Reisman, MD (2)  ·  Michael Burch, Prof,MD,PhD (2)  ·  Michiel Dalinghaus, MD,PhD (2)  ·  A Shash (1)  ·  Abd-Elmoneim Shawky Shams El-deen, MD (1)  ·  Abdel-Wahab El-Okby, MD (1)  ·  Ahmed Said Sayed Bayomy, MSc (1)  ·  Andrei Hancharou, Dr (1)  ·  Angelo E Schenone, MD (1)

Results publications

PMID 15107815, PMID 15701582, PMID 16219273, PMID 16322159, PMID 17307530, PMID 18254095, PMID 19128748, PMID 19217726, PMID 21051670, PMID 21525172, PMID 22065264, PMID 22170862, PMID 22417252, PMID 23234752, PMID 23321647, PMID 23341491, PMID 23543702, PMID 23771484, PMID 23796341, PMID 24753708, PMID 24815768, PMID 24824357, PMID 25046256, PMID 25147037, PMID 25346899, PMID 25835756, PMID 26283668, PMID 26811524, PMID 26824595, PMID 26951240, PMID 27733495, PMID 29138199, PMID 29222139, PMID 30520545, PMID 31211145, PMID 31217257, PMID 31574025, PMID 32034419, PMID 32865377, PMID 33186500, PMID 33447845, PMID 33497524, PMID 33692185, PMID 33832352, PMID 34629400, PMID 35234826, PMID 35391541, PMID 36038003, PMID 38101830, PMID 38709228

NIH funding

2015 (2), U54HD028138 (1)